Answers are grounded in this paper and cite their sources.
Randomized trial reports the effect and safety of ivabradine and metoprolol in acute myocardial infarction after percutaneous coronary intervention, highlighting combined cardiac therapy.
To investigate the effect and safety of the combined use of ivabradine and metoprolol in patients with acute myocardial infarction (AMI) after percutaneous coronary intervention (PCI).
No takes yet. Share an insight, caveat, or question.
He et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: